logo

Assertio Therapeutics Inc. (ASRT)



Trade ASRT now with
  Date
  Headline
12/15/2020 9:14:18 AM Assertio Plans Restructuring, To Cut Costs; Names Dan Peisert CEO
5/20/2020 8:50:33 AM Assertio Holdings Announces Closing Of Merger With Zyla Life Sciences
3/9/2020 4:09:31 PM Assertio Therapeutics Q4 Loss/share $2.65 Vs. Loss $0.38 Year Ago
8/9/2019 9:30:04 AM Assertio Reports Exchange Offer Of $200 Mln 2.50% Convertible Notes Due 2021
4/1/2019 9:09:44 AM Assertio Therapeutics Names Jay Galeota To Board
2/19/2019 8:36:43 AM Assertio Therapeutics Announces FDA Notification Of Acceptance For Filing Of 505(b)(2) NDA For Long-acting Cosyntropin
12/20/2018 9:13:58 AM Assertio Announces Submission Of NDA For FDA Approval Of Cosyntropin Depot